- 21 September
-
On September 11–17, 2026, Ekaterinburg hosted the International Youth Festival, a large-scale event that brought together 10,000 young leaders from 191 countries. At the festival running under the motto «Follow Your Dream,» the Medsintez Plant presented its exhibition, showcasing the achievements of the Ural pharmaceutical industry in the field of import substitution.
- 18 September
-
The updated clinical guidelines for treatment of ARVI in children took effect on September 2, 2026. The document was developed by leading experts from the Union of Pediatricians of Russia, the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC), and the Russian Society of Emergency Medical Care and approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation. It fundamentally shifts therapeutic approaches toward enhanced safety and minimal drug burden.
- 14 September
-
On September 3–4, 2026, Nizhny Novgorod hosted the 2nd Regional Endocrinological Congress: Challenges and Prospects of the Volga Region, with the active participation of the Medsintez Plant. As a strategic company, Medsintez Plant has been ensuring Russia's pharmaceutical security for 25 years. Company's exhibition booth showcased a range of hormonal medications for treatment of type 1 and type 2 diabetes, as well as drugs for infertility treatment through the IVF method.
- 04 September
-
More than twenty years ago, the Regiony Rossii (Regions of Russia, RR) magazine witnessed the birth of an innovative pharmaceutical production facility in Novouralsk, which had no analogues in the country. Today, the Medsintez Plant is a strategic asset in terms of national pharmaceutical security, a recognized industry leader, a National Champion, and a winner of prestigious awards. The secret behind the success of the Ural school of pharmaceuticals and biotechnology is explored in this article by RR.
- Home
- Cluster members
- Nipro PharmaPackaging Ural LLC
Nipro PharmaPackaging Ural LLC
Nipro PharmaPackaging Ural LLC is a 100% subsidiary of NIPRO (Japan).
The company is engaged in manufacture of primary glass packaging for pharmaceutical industry.
Ampoules, vials, cartridges are made exclusively of a glass tube of the 1st hydrolytic class Type I, in accordance with European, American, Japanese pharmacopoeias, of the following brands: NSV51 (manufacturer – Nipro PharmaPackaging), Fiolax (manufacturer Schott), FS5.0 (manufacturer Four Stars, China), JUNHENG (manufacturer – Triumph Junheng, China), Corning-51-D (China).
The range of products manufactured by the company includes:
• Ampoules: 1 to 25 ml, forms B, C, D, E; made of clear and amber glass, with open point cut or cut ring, in accordance with ISO 9187 It is possible to apply marker rings to the ampoules.
• Vials: 1 to 30 ml, made of clear and amber glass, with a crimp neck, in accordance with ISO 8362
• Cartridges with a nominal capacity of 1.5; 1.8; 3 ml; made of clear glass in accordance with ISO 13926
Technological lines are equipped with options for printing on products, which allows you to apply a company logo or other information, for additional protection of medicines against counterfeiting.
In addition to standard products, the company is capable to manufacture products in accordance with individual customer drawings.
otal production capacity is up to 300 million items per year. The plant is equipped with the latest equipment: European made ampoule and vial lines by OCMI (Italy), Euromatic (Italy), NCE (Belgium), a cartridge lines of own production by NIPRO (France). All technological lines are equipped with automated quality control systems VIMEC (Netherlands), which allows rejecting products for geometric, cosmetic and mechanical defects.
The company implemented a quality management system certified in accordance with ISO 9001:2015, ISO 15378 (Special requirements for ISO 9001:2008 implementation, taking into account Good Manufacturing Practice GMP).
Ilya Markovsky,
Director
+7 (912) 242-74-99
